Differential Effects of Nitric Oxide Synthase Inhibitors in Rats

Differential Effects of Nitric Oxide Synthase Inhibitors in Rats

<P> We investigated the action of NOS inhibitors on NOS in rats. Both of nitric oxide synthase inhibitors, N<SUP>G</SUP>-monomethyl-L-arginine (L-NMMA, 3μM) or N<SUP>G</SUP>-nitro-L-arginine methylester (L-NAME, 30μM), augmented phenylephrine (PE, 10<SUP>&#8291;7 </SUP>M)-induced contraction which was inhibited by acetylcholine (ACh) in rat thoracic aorta. This augmentation by L-NAME or L-NMMA was attenuated with the treatment of NO precursor, arginine. ACh, however, decreased the augmentation induced by L-NMMA, but not by L-NAME. Superoxide dismutase (SOD, 50 u/ml) potentiated an inhibitory effect of ACh on the PE (10<SUP>&#8291;7</SUP> M)-induced contraction. It has been known that platelet activating factor itself induces iNOS. Platelet activating factor (PAF, 10<SUP>&#8291;7</SUP> M) inhibited PE (10<SUP>&#8291;7</SUP> M)-induced contraction. Pretreatment with L-NMMA (30 mM) or L-NAME (30 mM) significantly blocked the inhibitory action of PAF on PE-induced contraction. L-NMMA (100 mM) or L-NAME (100 mM) reduced nerve conduction velocity (NCV) relevant to nNOS in rat sciatic nerve. ACh attenuated the reduction of NCV by L-NMMA-, but not by L-NAME-induced reduction of NCV. These results suggest that L-NMMA and/or L-NAME have different action on three types of NOS in rats.